Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ng CKY"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 28
Tytuł:
Investigation of Different Library Preparation and Tissue of Origin Deconvolution Methods for Urine and Plasma cfDNA Methylome Analysis.
Autorzy:
Kueng N; Department of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.
Sidler D; Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Banz V; Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Largiadèr CR; Department of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Ng CKY; Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland.
Amstutz U; Department of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Pokaż więcej
Źródło:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 Jul 27; Vol. 13 (15). Date of Electronic Publication: 2023 Jul 27.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Multi-omics subtyping of hepatocellular carcinoma patients using a Bayesian network mixture model.
Autorzy:
Suter P; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Dazert E; Biozentrum, University of Basel, Basel, Switzerland.
Kuipers J; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Ng CKY; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland.; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.
Boldanova T; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Hall MN; Biozentrum, University of Basel, Basel, Switzerland.
Heim MH; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Gastroenterology and Hepatology, Clarunis, University Center for Gastrointestinal and Liver Diseases, Basel, Switzerland.
Beerenwinkel N; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2022 Sep 06; Vol. 18 (9), pp. e1009767. Date of Electronic Publication: 2022 Sep 06 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/genetics
Bayes Theorem ; Cluster Analysis ; Humans ; Proteome ; Transcriptome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
Autorzy:
Bianco G; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
Coto-Llerena M; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Gallon J; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
Kancherla V; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Taha-Mehlitz S; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
Marinucci M; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
Konantz M; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.
Srivatsa S; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
Montazeri H; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.; Department of Bioinformatics, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Panebianco F; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
Tirunagaru VG; Rain Therapeutics Inc, Newark, CA, USA.
De Menna M; Department of Biomedical Research, Urology Group, University of Bern, Bern, Switzerland.
Paradiso V; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Ercan C; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Dahmani A; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie Research Center, Paris, France.
Montaudon E; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie Research Center, Paris, France.
Beerenwinkel N; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
Kruithof-de Julio M; Department of Biomedical Research, Urology Group, University of Bern, Bern, Switzerland.
Terracciano LM; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.; Department of Pathology, Humanitas Clinical and Research Center, IRCCS, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Lengerke C; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.
Jeselsohn RM; Division of Women's Cancers, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Doebele RC; Rain Therapeutics Inc, Newark, CA, USA.
Bidard FC; Department of Medical Oncology, Institut Curie, Saint Cloud, France.
Marangoni E; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie Research Center, Paris, France.
Ng CKY; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland. charlotte.ng@dbmr.unibe.ch.; Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland. charlotte.ng@dbmr.unibe.ch.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland. charlotte.ng@dbmr.unibe.ch.
Piscuoglio S; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland. .; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2022 Jul 04; Vol. 5 (1), pp. 658. Date of Electronic Publication: 2022 Jul 04.
Typ publikacji:
Published Erratum
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
Autorzy:
Bianco G; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
Coto-Llerena M; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Gallon J; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
Kancherla V; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Taha-Mehlitz S; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
Marinucci M; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
Konantz M; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.
Srivatsa S; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
Montazeri H; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.; Department of Bioinformatics, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Panebianco F; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
Tirunagaru VG; Rain Therapeutics Inc, Newark, CA, USA.
De Menna M; Department of Biomedical Research, Urology Group, University of Bern, Bern, Switzerland.
Paradiso V; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Ercan C; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Dahmani A; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie Research Center, Paris, France.
Montaudon E; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie Research Center, Paris, France.
Beerenwinkel N; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
Kruithof-de Julio M; Department of Biomedical Research, Urology Group, University of Bern, Bern, Switzerland.
Terracciano LM; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.; Department of Pathology, Humanitas Clinical and Research Center, IRCCS, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Lengerke C; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.
Jeselsohn RM; Division of Women's Cancers, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Doebele RC; Rain Therapeutics Inc, Newark, CA, USA.
Bidard FC; Department of Medical Oncology, Institut Curie, Saint Cloud, France.
Marangoni E; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie Research Center, Paris, France.
Ng CKY; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland. charlotte.ng@dbmr.unibe.ch.; Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland. charlotte.ng@dbmr.unibe.ch.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland. charlotte.ng@dbmr.unibe.ch.
Piscuoglio S; Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland. .; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2022 Apr 19; Vol. 5 (1), pp. 373. Date of Electronic Publication: 2022 Apr 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents*/therapeutic use
Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Female ; GATA3 Transcription Factor/genetics ; Humans ; Phosphatidylinositol 3-Kinases ; Proto-Oncogene Proteins c-mdm2/genetics ; Receptors, Estrogen/genetics ; Receptors, Estrogen/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The impact of chitosan on the early metabolomic response of wheat to infection by Fusarium graminearum.
Autorzy:
Deshaies M; UCD School of Biology and Environmental Science, UCD Centre for Plant Science, and UCD Earth Institute, University College Dublin, O'Brien Centre for Science, Belfield, Dublin, Ireland.; Envirotech Innovative Products Ltd, NovaUCD, Belfield Innovation Park, Belfield, Dublin, Ireland.
Lamari N; UCD School of Biology and Environmental Science, UCD Centre for Plant Science, and UCD Earth Institute, University College Dublin, O'Brien Centre for Science, Belfield, Dublin, Ireland.; Philip Morris International, Quai Jeanrenaud 3, 2000, Neuchatel, Switzerland.
Ng CKY; UCD School of Biology and Environmental Science, UCD Centre for Plant Science, and UCD Earth Institute, University College Dublin, O'Brien Centre for Science, Belfield, Dublin, Ireland.
Ward P; Envirotech Innovative Products Ltd, NovaUCD, Belfield Innovation Park, Belfield, Dublin, Ireland.
Doohan FM; UCD School of Biology and Environmental Science, UCD Centre for Plant Science, and UCD Earth Institute, University College Dublin, O'Brien Centre for Science, Belfield, Dublin, Ireland. .
Pokaż więcej
Źródło:
BMC plant biology [BMC Plant Biol] 2022 Feb 19; Vol. 22 (1), pp. 73. Date of Electronic Publication: 2022 Feb 19.
Typ publikacji:
Journal Article
MeSH Terms:
Chitosan/*pharmacology
Fusarium/*drug effects
Plant Diseases/*microbiology
Triticum/*drug effects
Triticum/*microbiology
Chromatography, High Pressure Liquid ; Cyclopentanes/metabolism ; Fungicides, Industrial/pharmacology ; Fusarium/growth & development ; Host-Pathogen Interactions/drug effects ; Mass Spectrometry ; Metabolome ; Oxylipins/metabolism ; Triticum/metabolism
SCR Organism:
Fusarium graminearum
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma.
Autorzy:
Dimitrakopoulos C; Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland.; Present address: Roche, PTD Biologics Europe, 4070, Basel, Switzerland.
Hindupur SK; Biozentrum, University of Basel, 4056, Basel, Switzerland.; Present address: Novartis Institutes for BioMedical Research, Disease Area Oncology, 4002, Basel, Switzerland.
Colombi M; Biozentrum, University of Basel, 4056, Basel, Switzerland.
Liko D; Biozentrum, University of Basel, 4056, Basel, Switzerland.
Ng CKY; Institute of Pathology, University Hospital Basel, 4031, Basel, Switzerland.; Department of BioMedical Research, University of Bern, 3008, Bern, Switzerland.
Piscuoglio S; Institute of Pathology, University Hospital Basel, 4031, Basel, Switzerland.; Department of Biomedicine, Visceral Surgery Research Laboratory, Clarunis, Basel, Switzerland.; Clarunis Universitäres Bauchzentrum Basel, Basel, Switzerland.
Behr J; Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland.
Moore AL; Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland.
Singer J; Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland.
Ruscheweyh HJ; Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland.
Matter MS; Institute of Pathology, University Hospital Basel, 4031, Basel, Switzerland.
Mossmann D; Biozentrum, University of Basel, 4056, Basel, Switzerland.
Terracciano LM; Institute of Pathology, University Hospital Basel, 4031, Basel, Switzerland.
Hall MN; Biozentrum, University of Basel, 4056, Basel, Switzerland. .
Beerenwinkel N; Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland. .; Swiss Institute of Bioinformatics, Basel, Switzerland. .
Pokaż więcej
Źródło:
BMC genomics [BMC Genomics] 2021 Aug 04; Vol. 22 (1), pp. 592. Date of Electronic Publication: 2021 Aug 04.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/drug therapy
Liver Neoplasms*/genetics
MicroRNAs*
Pharmaceutical Preparations*
Humans ; Transcriptome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 28

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies